Concepedia

Author

Bradley Vince

Altasciences Clinical Research Vince & Associates

Also Known As

B Vince, B. Vince, B.D. Vince, Bradley D. Vince, Bradley Vince

35

Publications

718

Citations

12

H-Index

49

Concepts

All Affiliations

Altasciences Clinical Research Vince & AssociatesUniversity of TorontoColumbia UniversityAlkermes (United States)Takeda (United States)
BV

About

Bradley Vince is an author at Altasciences Clinical Research Vince & Associates specializing in medicine, pharmacotherapy, and behavioral pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

114

2

Health Sciences

1

1

23

3

Social Sciences

1

1

52

4

Immunology

1

1

12

5

Neuroscience

1

1

52

Bradley Vince

×

16

Publications

650

Citations

12

H-Index

YearCitations

A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor

Lawrence P. Carter, Jack E. Henningfield, Y Grace Wang,

Journal of Psychopharmacology

2018

183

Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder

Sharon Walsh, Sandra D. Comer, Michelle R. Lofwall,

JAMA Psychiatry

2017

75

Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder

Azmi Nasser, Mark K. Greenwald, Bradley Vince,

Journal of Clinical Psychopharmacology

2015

74

A phase 1 study investigating DX-2930 in healthy subjects

Yung Chyung, Bradley Vince, Ryan Iarrobino,

Annals of Allergy Asthma & Immunology

2014

57

Psychomotor Functioning and Alertness with Guanfacine Extended Release in Subjects with Attention-Deficit/Hyperactivity Disorder

Scott H. Kollins, Frank A. López, Bradley Vince,

Journal of Child and Adolescent Psychopharmacology

2011

52

The Pharmacodynamics, Pharmacokinetics, and Safety of Arhalofenate in Combination with Febuxostat When Treating Hyperuricemia Associated with Gout

Alexandra Steinberg, Bradley Vince, Yun‐Jung Choi,

The Journal of Rheumatology

2016

36

Integrating<i>In Vitro</i>, Modeling, and<i>In Vivo</i>Approaches to Investigate Warfarin Bioequivalence

Xinyuan Zhang, Hao Wen, Jianghong Fan,

CPT Pharmacometrics & Systems Pharmacology

2017

27

A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4

Bradley Vince, John M. Hill, Eric Lawitz,

Journal of Hepatology

2014

23

A randomized, double‐blind, placebo‐controlled study of the kappa opioid receptor antagonist, CERC‐501, in a human laboratory model of smoking behavior

Jermaine D. Jones, Shanna Babalonis, Ronald N. Marcus,

Addiction Biology

2019

23

A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of ibezapolstat administered orally to healthy subjects

Kevin W. Garey, Khurshida Begum, Chris Lancaster,

Journal of Antimicrobial Chemotherapy

2020

23

Page 1